Works matching IS 21534888 AND DT 2021 AND VI 12 AND IP 2
Results: 20
Nivolumab plus Cabozantinib Superior to Sunitinib as First-Line Treatment for RCC.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 2, p. 18
- By:
- Publication type:
- Article
<sup>177</sup>Lu-PSMA-617 Superior to Cabazitaxel in Metastatic Prostate Cancer.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 2, p. 17
- By:
- Publication type:
- Article
Belzutifan: Novel Approach to Advanced RCC.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 2, p. 16
- By:
- Publication type:
- Article
Covid Lessons From Bush's Effort Against AIDS: Pressured to break drug patents in 2004, he came up with a better plan, an example for Biden.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 2, p. 14
- By:
- Publication type:
- Article
Watch Out for a Vaccine Patent Heist: The left wants Biden to force drug companies to give away their IP.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 2, p. 14
- Publication type:
- Article
Final Results from ClarIDHy: Ivosidenib Extends Survival in Patients with Cholangiocarcinoma and IDH1 Mutation.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 2, p. 13
- By:
- Publication type:
- Article
Zanidatamab Shows Promising Activity in Patients with HER2-Overexpressing Gastric Cancers.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 2, p. 12
- By:
- Publication type:
- Article
First CD73 Inhibitor Induces Responses in Patients with Metastatic Pancreatic Ductal Adenocarcinoma.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 2, p. 11
- By:
- Publication type:
- Article
First-Line Pembrolizumab plus Chemotherapy Extend Progression-Free Survival in Patients with Metastatic Triple-Negative Breast Cancer.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 2, p. 10
- By:
- Publication type:
- Article
Sacituzumab Govitecan Improves Progression-Free Survival in Metastatic Triple-Negative Breast Cancer with Brain Metastases.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 2, p. 9
- By:
- Publication type:
- Article
FDA NEWS.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 2, p. 7
- Publication type:
- Article
Nivolumab Monotherapy Extends Survival in Patients with Relapsed Malignant Mesothelioma.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 2, p. 7
- By:
- Publication type:
- Article
EGFR Most Common Mutation in Women with Lung Cancer and No Smoking History.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 2, p. 6
- By:
- Publication type:
- Article
LGBT Populations: Lung Cancer Screening Disparities Linked to Sexual Orientation.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 2, p. 5
- By:
- Publication type:
- Article
Sotorasib, First-in-Class KRAS p.G12C Inhibitor, Induces Durable Responses in Patients with Advanced NSCLC.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 2, p. 5
- By:
- Publication type:
- Article
Patients with Lung Cancer Distressed About Impact of COVID-19 on Access to Care.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 2, p. 4
- By:
- Publication type:
- Article
Bemarituzumab, FGFR2b Inhibitor, Improves Survival in Advanced Gastric Cancer with FGFR2b Mutation.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 2, p. 1
- By:
- Publication type:
- Article
Abemaciclib Added to Endocrine Therapy Reduces Invasive Disease Recurrence in High-Risk HR-Positive Early Breast Cancer: monarchE.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 2, p. 1
- By:
- Publication type:
- Article
Enfortumab Vedotin Extends Survival in Metastatic Urothelial Cancer.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 2, p. 1
- By:
- Publication type:
- Article
Later Diagnoses, Worse Outcomes in Patients with Lung Cancer During COVID-19 May Last.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 2, p. 1
- By:
- Publication type:
- Article